I have suffered with migraines on and off for about five years. Recently, the oral therapy I've used seems to be less effective. While I know newer medications are available, a friend suggested I try Botox injections. She ...
Sep 20, 2022
0
10
James McKerrow, MD, Ph.D., dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, has long studied neglected tropical diseases—chronic and disabling parasitic infections ...
Apr 2, 2021
0
79
A new study suggests that a Sinopharm vaccine offers poor protection from COVID-19 among the elderly, raising questions for dozens of countries that have given the Chinese company's shots to their most vulnerable populations.
Jul 23, 2021
0
454
(HealthDay)—For people with psoriasis, "freedom from disease" is a multicomponent concept that includes five main domains, according to research published online Nov. 24 in the Journal of the European Academy of Dermatology ...
Dec 21, 2021
0
12
Awakening the immune system's instinct for destroying cancer, using two molecules located on the surface of macrophages: that's the promising avenue opening up from recent laboratory work of Dr. André Veillette.
Jan 18, 2022
0
108
US biotech company Moderna announced COVID vaccine is 90 percent effective against all forms of the disease and 95 percent effective against severe disease.
Apr 14, 2021
0
55
Over a year into global COVID-19 vaccination efforts the question of whether jab formulas ought to be freely available is still unresolved—and undersupplied countries are turning to workarounds.
Jan 17, 2022
0
19
More effective antiviral treatments could be on the way after research from The University of Texas at Austin sheds new light on the COVID-19 antiviral drug remdesivir, the only treatment of its kind currently approved in ...
Jan 28, 2021
0
171
The number of privately insured adults in the United States prescribed opioid medications for cancer pain and for chronic non-cancer pain declined between 2012 and 2019, according to a new study published this week in the ...
Aug 10, 2022
1
27
An exploratory analysis of data from the SURPASS-4 trial has shown that adults with type 2 diabetes and increased cardiovascular risk receiving tirzepatide experience fewer renal complications, especially new onset of macroalbuminuria; ...
Jun 6, 2022
0
7
